Search research articles
Contact Us
Filters
Showing results (61-70 of 183) with videos related to
Page
of 19
Sort By:
Alzheimer'S Research & Therapy
|
December 20, 2025
Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study
Che-Yuan Wu, Wajd Alkabbani, Baiju R Shah, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease
Walter Swardfager, Nathan Herrmann, Susan Marzolini, et al.
Neuroscience and Biobehavioral Reviews
|
April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Walter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Sofia Perfetto, Myuri Ruthirakuhan, Yuen Yan Wong, et al.
International Journal of Geriatric Psychiatry
|
May 6, 2017
Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation
Calvin Santiago, Nathan Herrmann, Walter Swardfager, et al.
Neuropsychiatric Disease and Treatment
|
September 22, 2010
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al.
Neuroscience and Biobehavioral Reviews
|
June 27, 2013
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration
Graham Mazereeuw, Nathan Herrmann, Steffany A L Bennett, et al.
Brain Communications
|
September 25, 2025
Thalamus anatomy predicts cognitive performance and hippocampal atrophy in aging adults: a UK Biobank study
Guocheng Jiang, Fa-Hsuan Lin, Hugo Cogo-Moreira, et al.
CNS Drugs
|
February 26, 2026
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis
Tiffany J Pan, Hui Jue Wang, Almira Siddiqui, et al.
Human Brain Mapping
|
October 26, 2019
Metabolic and vascular risk factors are associated with reduced cerebral blood flow and poorer midlife memory performance
Bradley J MacIntosh, Zahra Shirzadi, Sarah Atwi, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 183) with videos related to
Sort By:
Page
of 19
Alzheimer'S Research & Therapy
|
December 20, 2025
Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study
Che-Yuan Wu, Wajd Alkabbani, Baiju R Shah, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease
Walter Swardfager, Nathan Herrmann, Susan Marzolini, et al.
Neuroscience and Biobehavioral Reviews
|
April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Walter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Sofia Perfetto, Myuri Ruthirakuhan, Yuen Yan Wong, et al.
International Journal of Geriatric Psychiatry
|
May 6, 2017
Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation
Calvin Santiago, Nathan Herrmann, Walter Swardfager, et al.
Neuropsychiatric Disease and Treatment
|
September 22, 2010
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al.
Neuroscience and Biobehavioral Reviews
|
June 27, 2013
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration
Graham Mazereeuw, Nathan Herrmann, Steffany A L Bennett, et al.
Brain Communications
|
September 25, 2025
Thalamus anatomy predicts cognitive performance and hippocampal atrophy in aging adults: a UK Biobank study
Guocheng Jiang, Fa-Hsuan Lin, Hugo Cogo-Moreira, et al.
CNS Drugs
|
February 26, 2026
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis
Tiffany J Pan, Hui Jue Wang, Almira Siddiqui, et al.
Human Brain Mapping
|
October 26, 2019
Metabolic and vascular risk factors are associated with reduced cerebral blood flow and poorer midlife memory performance
Bradley J MacIntosh, Zahra Shirzadi, Sarah Atwi, et al.
Page
of 19